Longevity Science vs CRISPR Telomerase - 3 Hidden Hurdles
Reactivating telomerase can shrink a therapy's timeline to as little as 12 months, turning a decade-long dream into a near-term product. By directly lengthening chromosome caps, the approach promises rapid health-span gains, but three hidden hurdles keep it from mainstream launch. Longevity Science Foundations for Scaling Gene-Editing Startups